U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C30H47O3.Na
Molecular Weight 478.6821
Optical Activity UNSPECIFIED
Defined Stereocenters 10 / 10
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SODIUM URSOLATE

SMILES

[Na+].C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]2[C@H]1C)C([O-])=O

InChI

InChIKey=DUAZSEDLBBRXQJ-ANQQBNRBSA-M
InChI=1S/C30H48O3.Na/c1-18-10-15-30(25(32)33)17-16-28(6)20(24(30)19(18)2)8-9-22-27(5)13-12-23(31)26(3,4)21(27)11-14-29(22,28)7;/h8,18-19,21-24,31H,9-17H2,1-7H3,(H,32,33);/q;+1/p-1/t18-,19+,21+,22-,23+,24+,27+,28-,29-,30+;/m1./s1

HIDE SMILES / InChI

Molecular Formula C30H47O3
Molecular Weight 455.6924
Charge -1
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 10 / 10
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula Na
Molecular Weight 22.98976928
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/24374755 | https://www.ncbi.nlm.nih.gov/pubmed/23499879 | https://www.ncbi.nlm.nih.gov/pubmed/26610440 | https://www.ncbi.nlm.nih.gov/pubmed/26775565

Ursolic acid is a natural terpene compond found in a wide variety of plants but most well known for being in apple peels. Ursolic acid has a series of biological effects such as sedative, anti-inflammatory, anti-bacterial, anti-diabetic, antiulcer, antitumor etc. Ursolic acid has been shown to target multiple proinflammatory transcription factors, cell cycle proteins, growth factors, kinases, cytokines, chemokines, adhesion molecules, and inflammatory enzymes. Evidences suggest that ursolic acid could be used as a potential candidate to develop a comprehensive competent strategy towards the treatment and prevention of health disorders. Although the science is preliminary, it seems to be able to reduce fat accumulation and increase muscle mass gain when in a fed state, and to induce fat burning and preserve muscle mass when in a fasted state.

Originator

Sources: Trommsdorff, H., Arch. Pharm., 80, 273 (1854)

Approval Year

TargetsConditions

Conditions

Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
1211 ng/mL
74 mg/m² 1 times / day multiple, intravenous
dose: 74 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
URSOLIC ACID plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
3457 ng/mL
98 mg/m² single, intravenous
dose: 98 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
URSOLIC ACID plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
2865 ng/mL
74 mg/m² single, intravenous
dose: 74 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
URSOLIC ACID plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
1835 μg/mL
37 mg/m² single, intravenous
dose: 37 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
URSOLIC ACID plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
4834 ng × h/mL
74 mg/m² 1 times / day multiple, intravenous
dose: 74 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
URSOLIC ACID plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
9696 ng × h/mL
98 mg/m² single, intravenous
dose: 98 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
URSOLIC ACID plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
7175 ng × h/mL
74 mg/m² single, intravenous
dose: 74 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
URSOLIC ACID plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
4203 ng × h/mL
37 mg/m² single, intravenous
dose: 37 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
URSOLIC ACID plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
4 h
74 mg/m² 1 times / day multiple, intravenous
dose: 74 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
URSOLIC ACID plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
3.9 h
98 mg/m² single, intravenous
dose: 98 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
URSOLIC ACID plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
4.46 h
74 mg/m² single, intravenous
dose: 74 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
URSOLIC ACID plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
4.59 h
37 mg/m² single, intravenous
dose: 37 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
URSOLIC ACID plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
Doses

Doses

DosePopulationAdverse events​
130 mg/m2 single, intravenous
Highest studied dose
Dose: 130 mg/m2
Route: intravenous
Route: single
Dose: 130 mg/m2
Sources:
unhealthy
Health Status: unhealthy
Sex: M
Food Status: UNKNOWN
Sources:
DLT: ALT increased, AST increased...
Other AEs: GGT increased...
Dose limiting toxicities:
ALT increased (grade 3, 2 patients)
AST increased (grade 3, 2 patients)
Direct bilirubin increased (grade 3, 2 patients)
Other AEs:
GGT increased (grade 2, 2 patients)
Sources:
94 mg/m2 single, intravenous
MTD
Dose: 94 mg/m2
Route: intravenous
Route: single
Dose: 94 mg/m2
Sources:
unhealthy
Health Status: unhealthy
Sex: M+F
Food Status: UNKNOWN
Sources:
DLT: ALT increased, GGT increased...
Other AEs: AST increased...
Dose limiting toxicities:
ALT increased (grade 3, 1 pt)
GGT increased (grade 3, 1 pt)
Other AEs:
AST increased (grade 2, 2 patients)
Sources:
74 mg/m2 single, intravenous
Studied dose
Dose: 74 mg/m2
Route: intravenous
Route: single
Dose: 74 mg/m2
Sources:
unhealthy
Health Status: unhealthy
Sex: M+F
Food Status: UNKNOWN
Sources:
DLT: AST increased, ALT increased...
Dose limiting toxicities:
AST increased (grade 3, 1 pt)
ALT increased (grade 3, 1 pt)
diarrhea (grade 3, 1 pt)
Sources:
AEs

AEs

AESignificanceDosePopulation
GGT increased grade 2, 2 patients
130 mg/m2 single, intravenous
Highest studied dose
Dose: 130 mg/m2
Route: intravenous
Route: single
Dose: 130 mg/m2
Sources:
unhealthy
Health Status: unhealthy
Sex: M
Food Status: UNKNOWN
Sources:
ALT increased grade 3, 2 patients
DLT
130 mg/m2 single, intravenous
Highest studied dose
Dose: 130 mg/m2
Route: intravenous
Route: single
Dose: 130 mg/m2
Sources:
unhealthy
Health Status: unhealthy
Sex: M
Food Status: UNKNOWN
Sources:
AST increased grade 3, 2 patients
DLT
130 mg/m2 single, intravenous
Highest studied dose
Dose: 130 mg/m2
Route: intravenous
Route: single
Dose: 130 mg/m2
Sources:
unhealthy
Health Status: unhealthy
Sex: M
Food Status: UNKNOWN
Sources:
Direct bilirubin increased grade 3, 2 patients
DLT
130 mg/m2 single, intravenous
Highest studied dose
Dose: 130 mg/m2
Route: intravenous
Route: single
Dose: 130 mg/m2
Sources:
unhealthy
Health Status: unhealthy
Sex: M
Food Status: UNKNOWN
Sources:
AST increased grade 2, 2 patients
94 mg/m2 single, intravenous
MTD
Dose: 94 mg/m2
Route: intravenous
Route: single
Dose: 94 mg/m2
Sources:
unhealthy
Health Status: unhealthy
Sex: M+F
Food Status: UNKNOWN
Sources:
ALT increased grade 3, 1 pt
DLT
94 mg/m2 single, intravenous
MTD
Dose: 94 mg/m2
Route: intravenous
Route: single
Dose: 94 mg/m2
Sources:
unhealthy
Health Status: unhealthy
Sex: M+F
Food Status: UNKNOWN
Sources:
GGT increased grade 3, 1 pt
DLT
94 mg/m2 single, intravenous
MTD
Dose: 94 mg/m2
Route: intravenous
Route: single
Dose: 94 mg/m2
Sources:
unhealthy
Health Status: unhealthy
Sex: M+F
Food Status: UNKNOWN
Sources:
ALT increased grade 3, 1 pt
DLT
74 mg/m2 single, intravenous
Studied dose
Dose: 74 mg/m2
Route: intravenous
Route: single
Dose: 74 mg/m2
Sources:
unhealthy
Health Status: unhealthy
Sex: M+F
Food Status: UNKNOWN
Sources:
AST increased grade 3, 1 pt
DLT
74 mg/m2 single, intravenous
Studied dose
Dose: 74 mg/m2
Route: intravenous
Route: single
Dose: 74 mg/m2
Sources:
unhealthy
Health Status: unhealthy
Sex: M+F
Food Status: UNKNOWN
Sources:
diarrhea grade 3, 1 pt
DLT
74 mg/m2 single, intravenous
Studied dose
Dose: 74 mg/m2
Route: intravenous
Route: single
Dose: 74 mg/m2
Sources:
unhealthy
Health Status: unhealthy
Sex: M+F
Food Status: UNKNOWN
Sources:
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
A new pentacyclic triterpenoid glucoside from Prunus serrulata var. spontanea.
2004-01
Epicuticular waxes from caatinga and cerrado species and their efficiency against water loss.
2003-12
Antiplasmodial triterpenes from twigs of Gardenia saxatilis.
2003-10
A review of natural and modified betulinic, ursolic and echinocystic acid derivatives as potential antitumor and anti-HIV agents.
2003-09
Inhibition of ultraviolet-A-modulated signaling pathways by asiatic acid and ursolic acid in HaCaT human keratinocytes.
2003-08-29
Ursolic acid inhibits proliferation and stimulates apoptosis in HT29 cells following activation of alkaline sphingomyelinase.
2003-08-21
High-performance liquid chromatographic analysis of bioactive triterpenes in Perilla frutescens.
2003-08-21
Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1.
2003-08-01
[Effects of ursolic acid on liver-protection and bile secretion].
2003-08
Sterols and triterpenes in cell culture of Hyssopus officinalis L.
2003-07-23
MECC determination of oleanolic acid and ursolic acid isomers in Ligustrum lucidum Ait.
2003-07-14
The role of hydrogen peroxide produced by polychlorinated biphenyls in PMR1-deficient yeast cells.
2003-07
In vitro TGF-beta1 antagonistic activity of ursolic and oleanolic acids isolated from Clerodendranthus spicatus.
2003-07
Immunomodulatory activities of flavonoids, monoterpenoids, triterpenoids, iridoid glycosides and phenolic compounds of Plantago species.
2003-07
Ursolic acid induces apoptosis through caspase-3 activation and cell cycle arrest in HaCat cells.
2003-07
[Chemical constituents in the roots of Salvia przewalskii Maxim].
2003-05
Sterol and triterpenoid constituents of Verbena littoralis with NGF-potentiating activity.
2003-05
Biological activity of some naturally occurring resins, gums and pigments against in vitro LDL oxidation.
2003-05
Development of LC-MS method for determination of ursolic acid: application to the analysis of ursolic acid in Staphylea holocarpa Hemsl.
2003-04-01
New ursolic and betulinic derivatives as potential cytotoxic agents.
2003-04
Eremophilenolides and other constituents from the roots of Ligularia sagitta.
2003-04
A new in vitro tissue factor inhibitory triterpene from the fruits of Chaenomeles sinensis.
2003-04
Antifeedant activity of some pentacyclic triterpene acids and their fatty acid ester analogues.
2003-03-26
Cardiovascular, antihyperlipidemic and antioxidant effects of oleanolic and ursolic acids in experimental hypertension.
2003-03
New cytotoxic lupane triterpenoids from the twigs of Coussarea paniculata.
2003-03
CNS activity of the methanol extract of Mallotus peltatus (Geist) Muell Arg. leaf: an ethnomedicine of Onge.
2003-03
Antihypertensive, antiatherosclerotic and antioxidant activity of triterpenoids isolated from Olea europaea, subspecies africana leaves.
2003-02
In vivo anti-nociceptive and anti-inflammatory effect of the two triterpenes, ursolic acid and 23-hydroxyursolic acid, from Cussonia bancoensis.
2003-02
Natural anti-HIV agents. Part IV. Anti-HIV constituents from Vatica cinerea.
2003-02
Isolation, characterization and biological activity of betulinic acid and ursolic acid from Vitex negundo L.
2003-02
Biomass segregation in sage cell suspension culture.
2003-01
Cytotoxic triterpenes from the twigs of Celtis philippinensis.
2003-01
Effect of naturally occurring triterpenoids glycyrrhizic acid, ursolic acid, oleanolic acid and nomilin on the immune system.
2003
The triterpenoid CDDO inhibits expression of matrix metalloproteinase-1, matrix metalloproteinase-13 and Bcl-3 in primary human chondrocytes.
2003
Antileukemic activity of selected natural products in Taiwan.
2003
[Comparative study of the spectral characteristics of ursolic acid between laser Raman spectra and IR spectrum].
2002-12
[Determination of ursolic acid in herba of Verbena officinalis by HPLC].
2002-12
Biosynthesis of sterols and triterpenes in cell suspension cultures of Uncaria tomentosa.
2002-12
Antithrombin activity of some constituents from Origanum vulgare.
2002-12
Alysinol--a new triterpene from Alysicarpus monolifer.
2002-12
[Studies on chemical constituents in fruit of Eucalyptus globulus].
2002-08
[Chemical composition of fructus Liquidambaris--lulutong].
2002-04
Inhibitory activity of minor polyphenolic and nonpolyphenolic constituents of olive oil against in vitro low-density lipoprotein oxidation.
2002
[Studies on chemical constituents of Gaultheria leucocarpa var. Yunnanensis (Franch.) T. Z. Hsu & R. C. Fang].
2001-12
[HPLC determination of oleanolic acid and llrolic acid in Chinese medicinal herbs].
2001-09
[Studies on the triterpenoidal saponins from flowers of Eriobotrya japonica].
2001-06
[Isolation and elucidation of chemical constituents of Shandanshaoyao Decoction(I)].
2001-06
[Lipid chemical constituents of Salvia sochifolia C. Y. Wu].
2001-04
[The research on the chemical components of Schizonepeta tenuifolia Briq].
2001-03
Oleanolic acid from cranberries.
1953-10
Patents

Sample Use Guides

In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Mon Mar 31 21:01:05 GMT 2025
Edited
by admin
on Mon Mar 31 21:01:05 GMT 2025
Record UNII
NV5D25VL1O
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SODIUM URSOLATE
INCI  
INCI  
Official Name English
DUBOISIA URSOLIC ACID, SODIUM SALT, PREMIER
Preferred Name English
URS-12-EN-28-OIC ACID, 3-HYDROXY-, SODIUM SALT (1:1), (3.BETA.)-
Common Name English
URS-12-3EN-28-OIC ACID, 3-HYDROXY-, MONOSODIUM SALT, (3-.BETA.)-
Common Name English
Code System Code Type Description
PUBCHEM
71587647
Created by admin on Mon Mar 31 21:01:05 GMT 2025 , Edited by admin on Mon Mar 31 21:01:05 GMT 2025
PRIMARY
RXCUI
1366935
Created by admin on Mon Mar 31 21:01:05 GMT 2025 , Edited by admin on Mon Mar 31 21:01:05 GMT 2025
PRIMARY RxNorm
DAILYMED
NV5D25VL1O
Created by admin on Mon Mar 31 21:01:05 GMT 2025 , Edited by admin on Mon Mar 31 21:01:05 GMT 2025
PRIMARY
EPA CompTox
DTXSID90176521
Created by admin on Mon Mar 31 21:01:05 GMT 2025 , Edited by admin on Mon Mar 31 21:01:05 GMT 2025
PRIMARY
FDA UNII
NV5D25VL1O
Created by admin on Mon Mar 31 21:01:05 GMT 2025 , Edited by admin on Mon Mar 31 21:01:05 GMT 2025
PRIMARY
CAS
220435-39-2
Created by admin on Mon Mar 31 21:01:05 GMT 2025 , Edited by admin on Mon Mar 31 21:01:05 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE